News - Hikma Pharmaceuticals, Sinclair IS Pharma

Filter

Popular Filters

1 to 25 of 31 results

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

12-03-2014

Jordon-headquartered Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialGenericsHikma Pharmaceuticals

Hikma in $40 million deal to enhance delivery of generic injectables

20-11-2013

USA-based Unilife Corp has signed a long-term commercial supply contract with Jordan-headquartered Hikma…

GenericsHikma PharmaceuticalsLicensingMarkets & MarketingUnilife Corp

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Hikma first half EPS beats expectations; raises guidance

21-08-2013

Jordan-headquartered drugmaker Hikma Pharmaceuticals (HIK: LSE) this morning (August 21) reported financial…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Jordon's Hikma upgrades 2013 guidance

08-07-2013

Jordon-based Hikma Pharmaceuticals (LSE: HIK) has issued an upgraded guidance for 2013, saying that its…

FinancialGenericsHikma Pharmaceuticals

Hikma licenses Vibativ from Theravance for MENA region

02-07-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

Hikma to retain its global Injectables business

17-04-2013

Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

19-03-2013

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

Hikma delivers revenue growth of 21% and EPS up 24% for 2012

13-03-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region

22-10-2012

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

Sinclair IS partners with Quintiles to commercialize portfolio in Mexico

13-09-2012

UK-based Sinclair IS Pharma (AIM: SPH.L) yesterday announced the signing of a 10-year collaboration and…

DermatologicalsLicensingMarkets & MarketingPharmaceuticalQuintilesSinclair IS PharmaSouth America

Solid first-half 2012 results from Jordan's Hikma

16-08-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) has reported its interim results for…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Sinclair IS returns Episil rights to Camurus, retaining some distribution

04-07-2012

UK-based specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) has returned the commercial rights for Episil(…

CamurusEpisilLicensingNeurologicalPharmaceuticalSinclair IS Pharma

Hikma may invest $100 million in Ukrainian pharma market

15-05-2012

Hikma Pharmaceuticals (LSE: HIK), Jordan's largest pharmaceutical company which is listed on the London…

EuropeFinancialGenericsHikma Pharmaceuticals

Hikma earnings down despite 25.6% revenue growth

14-03-2012

Fast-growing Jordan headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) delivered what it called…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Sinclair IS Pharma divests Mysoline to Lab SERB for £11 million

15-11-2011

UK specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) says it has disposed of the epilepsy drug Mysoline…

Laboratoires SERBMergers & AcquisitionsMysolineNeurologicalPharmaceuticalSinclair IS Pharma

Hikma enters Moroccan market via $111 million controlling stake in Promopharm

05-10-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Hikma unit to increase focus on contract manufacturing, aimed at alleviating US drug shortages

20-09-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that its US subsidiary, West-Ward, is to focus…

GenericsHikma PharmaceuticalsMarkets & MarketingNorth AmericaWest-Ward

1 to 25 of 31 results

Back to top